Lori A Zoellner Selected Research

Phobic Disorders (Phobia)

7/2017

Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lori A Zoellner Research Topics

Disease

34	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2021 - 08/2002
7	Wounds and Injuries (Trauma) 01/2022 - 08/2003
2	Symptom Flare Up 12/2020 - 08/2002
1	Parkinson Disease (Parkinson's Disease) 10/2019
1	Substance-Related Disorders (Drug Abuse) 01/2018
1	Phobic Disorders (Phobia) 07/2017

Drug/Important Bio-Agent (IBA)

27	Sertraline (Zoloft)FDA LinkGeneric 12/2021 - 08/2003
2	Pharmaceutical PreparationsIBA 01/2018 - 07/2017
1	BuffersIBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2018
1	Gonadal HormonesIBA 12/2018
1	Progesterone FDA LinkGeneric 12/2018
1	Estrogens (Estrogen)FDA Link 12/2018
1	Methylene Blue (Methylthioninium Chloride)FDA Link 07/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2016

Therapy/Procedure

8	Therapeutics 12/2021 - 08/2002
7	Drug Therapy (Chemotherapy) 12/2020 - 09/2009
1	Aftercare (After-Treatment) 01/2018
1	Contraindications 08/2014